Authors :
Dr. Pooja Prakash Liman; Dr. Mrinal Ashish Nerlekar
Volume/Issue :
Volume 9 - 2024, Issue 2 - February
Google Scholar :
http://tinyurl.com/3m4zuz9s
Scribd :
http://tinyurl.com/3tcdd76a
DOI :
https://doi.org/10.5281/zenodo.10663003
Abstract :
Abstract:- Homoeopathy is one of the most widely used
alternative therapies, utilized all over the world, and is
important in the treatment of many different illnesses. The
most frequently used homeopathic medications for
diabetes include Cephalandra indica, Syzygium
jambolanum, phosphoric acid, Gymnema sylvestre, and
Uranium nitricum. The mother tincture form is utilized as
a physiological active dose according to the patient's
requirements and blood glucose level.
Aim and objective –
This study aimed to gather and analyze data from
previous studies, in addition to examining and evaluating
the anti-diabetic efficacy of Cephalandra indica and
Gymnema sylvestre.
Methodology-
This review covers articles that appeared until 2023.
The articles were gathered using databases like Google
Scholar and PubMed (Medline). We used the terms
"homoeopathy," "diabetes," "in vitro," "in vivo,"
"Gymnema Sylvester,” and "Cephalandra indica."
Result-
The review contained both in vitro and in vivo
research from earlier publications. This review paper
presents scientific validation for the pharmacological
efficacy of Cephalandra indica and Gymnema sylvestre, as
well as the likely mechanism of action shown in preclinical
research.
Conclusion-
Preclinical studies on homeopathic preparations of
Gymnema sylvestre and Cephalandra indica have shown
zero cytotoxicity, and they have a pharmacological and
safety profile. The review contained both invitro and
invivo research from earlier publications. In this review
paper, the pharmacological activity of Cephalandra indica
and Gymnema sylvestre, together with the likely
mechanism of action revealed by preclinical studies, were
validated scientifically. With proper research, the
postulated dose conversion theory has to be verified. An
overview of the existing studies on these two homoeopathic
medicines is required. Despite adequate background data,
human trials on diabetes mellitus using these drug
candidates are lacking.
Keywords :
Cephalandra indica, Diabetes, Gymnema sylvestre, in Vivo, in Vitro, Preclinical Study.
Abstract:- Homoeopathy is one of the most widely used
alternative therapies, utilized all over the world, and is
important in the treatment of many different illnesses. The
most frequently used homeopathic medications for
diabetes include Cephalandra indica, Syzygium
jambolanum, phosphoric acid, Gymnema sylvestre, and
Uranium nitricum. The mother tincture form is utilized as
a physiological active dose according to the patient's
requirements and blood glucose level.
Aim and objective –
This study aimed to gather and analyze data from
previous studies, in addition to examining and evaluating
the anti-diabetic efficacy of Cephalandra indica and
Gymnema sylvestre.
Methodology-
This review covers articles that appeared until 2023.
The articles were gathered using databases like Google
Scholar and PubMed (Medline). We used the terms
"homoeopathy," "diabetes," "in vitro," "in vivo,"
"Gymnema Sylvester,” and "Cephalandra indica."
Result-
The review contained both in vitro and in vivo
research from earlier publications. This review paper
presents scientific validation for the pharmacological
efficacy of Cephalandra indica and Gymnema sylvestre, as
well as the likely mechanism of action shown in preclinical
research.
Conclusion-
Preclinical studies on homeopathic preparations of
Gymnema sylvestre and Cephalandra indica have shown
zero cytotoxicity, and they have a pharmacological and
safety profile. The review contained both invitro and
invivo research from earlier publications. In this review
paper, the pharmacological activity of Cephalandra indica
and Gymnema sylvestre, together with the likely
mechanism of action revealed by preclinical studies, were
validated scientifically. With proper research, the
postulated dose conversion theory has to be verified. An
overview of the existing studies on these two homoeopathic
medicines is required. Despite adequate background data,
human trials on diabetes mellitus using these drug
candidates are lacking.
Keywords :
Cephalandra indica, Diabetes, Gymnema sylvestre, in Vivo, in Vitro, Preclinical Study.
